Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same

The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jang, Young Koo, Kim, Ji Yeon, Cha, Soo Bong, Cho, Nahm Ryune, Min, Hye Kyung, Jung, Hyo Jun, Choi, Eun Ju, Lee, Ji Won, Han, Seung Nam, Chung, Jin Yong, Ham, Seung Mo, Maeng, Cheol Young, Lee, Ju Young, Shin, Yong Je, Kim, Yong Gil, Joung, Chan Mi, Park, Jong Sil, Ryu, Eun Ju, Park, Chun Eung
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Jang, Young Koo
Kim, Ji Yeon
Cha, Soo Bong
Cho, Nahm Ryune
Min, Hye Kyung
Jung, Hyo Jun
Choi, Eun Ju
Lee, Ji Won
Han, Seung Nam
Chung, Jin Yong
Ham, Seung Mo
Maeng, Cheol Young
Lee, Ju Young
Shin, Yong Je
Kim, Yong Gil
Joung, Chan Mi
Park, Jong Sil
Ryu, Eun Ju
Park, Chun Eung
description The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016224227BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016224227BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016224227BB23</originalsourceid><addsrcrecordid>eNqNjL0KwkAQhK-xEPUdrrBU0FW0NqJor3VY7jZmIffD3RowT2-MPoDVfHwzzFjZq2OLXYivxD2xJ43eav5aSYzdx1lK3KJwS4uhjzUmh4aewgYbbYKLIbNw8AMnzuwfWmrSGR1N1ajCJtPslxM1P59ux8uSYigpx_7Ik5SHO6zWO4AtwL4oYPPn7A0kdkF1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same</title><source>esp@cenet</source><creator>Jang, Young Koo ; Kim, Ji Yeon ; Cha, Soo Bong ; Cho, Nahm Ryune ; Min, Hye Kyung ; Jung, Hyo Jun ; Choi, Eun Ju ; Lee, Ji Won ; Han, Seung Nam ; Chung, Jin Yong ; Ham, Seung Mo ; Maeng, Cheol Young ; Lee, Ju Young ; Shin, Yong Je ; Kim, Yong Gil ; Joung, Chan Mi ; Park, Jong Sil ; Ryu, Eun Ju ; Park, Chun Eung</creator><creatorcontrib>Jang, Young Koo ; Kim, Ji Yeon ; Cha, Soo Bong ; Cho, Nahm Ryune ; Min, Hye Kyung ; Jung, Hyo Jun ; Choi, Eun Ju ; Lee, Ji Won ; Han, Seung Nam ; Chung, Jin Yong ; Ham, Seung Mo ; Maeng, Cheol Young ; Lee, Ju Young ; Shin, Yong Je ; Kim, Yong Gil ; Joung, Chan Mi ; Park, Jong Sil ; Ryu, Eun Ju ; Park, Chun Eung</creatorcontrib><description>The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200116&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016224227B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200116&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016224227B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Jang, Young Koo</creatorcontrib><creatorcontrib>Kim, Ji Yeon</creatorcontrib><creatorcontrib>Cha, Soo Bong</creatorcontrib><creatorcontrib>Cho, Nahm Ryune</creatorcontrib><creatorcontrib>Min, Hye Kyung</creatorcontrib><creatorcontrib>Jung, Hyo Jun</creatorcontrib><creatorcontrib>Choi, Eun Ju</creatorcontrib><creatorcontrib>Lee, Ji Won</creatorcontrib><creatorcontrib>Han, Seung Nam</creatorcontrib><creatorcontrib>Chung, Jin Yong</creatorcontrib><creatorcontrib>Ham, Seung Mo</creatorcontrib><creatorcontrib>Maeng, Cheol Young</creatorcontrib><creatorcontrib>Lee, Ju Young</creatorcontrib><creatorcontrib>Shin, Yong Je</creatorcontrib><creatorcontrib>Kim, Yong Gil</creatorcontrib><creatorcontrib>Joung, Chan Mi</creatorcontrib><creatorcontrib>Park, Jong Sil</creatorcontrib><creatorcontrib>Ryu, Eun Ju</creatorcontrib><creatorcontrib>Park, Chun Eung</creatorcontrib><title>Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same</title><description>The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjL0KwkAQhK-xEPUdrrBU0FW0NqJor3VY7jZmIffD3RowT2-MPoDVfHwzzFjZq2OLXYivxD2xJ43eav5aSYzdx1lK3KJwS4uhjzUmh4aewgYbbYKLIbNw8AMnzuwfWmrSGR1N1ajCJtPslxM1P59ux8uSYigpx_7Ik5SHO6zWO4AtwL4oYPPn7A0kdkF1</recordid><startdate>20200116</startdate><enddate>20200116</enddate><creator>Jang, Young Koo</creator><creator>Kim, Ji Yeon</creator><creator>Cha, Soo Bong</creator><creator>Cho, Nahm Ryune</creator><creator>Min, Hye Kyung</creator><creator>Jung, Hyo Jun</creator><creator>Choi, Eun Ju</creator><creator>Lee, Ji Won</creator><creator>Han, Seung Nam</creator><creator>Chung, Jin Yong</creator><creator>Ham, Seung Mo</creator><creator>Maeng, Cheol Young</creator><creator>Lee, Ju Young</creator><creator>Shin, Yong Je</creator><creator>Kim, Yong Gil</creator><creator>Joung, Chan Mi</creator><creator>Park, Jong Sil</creator><creator>Ryu, Eun Ju</creator><creator>Park, Chun Eung</creator><scope>EVB</scope></search><sort><creationdate>20200116</creationdate><title>Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same</title><author>Jang, Young Koo ; Kim, Ji Yeon ; Cha, Soo Bong ; Cho, Nahm Ryune ; Min, Hye Kyung ; Jung, Hyo Jun ; Choi, Eun Ju ; Lee, Ji Won ; Han, Seung Nam ; Chung, Jin Yong ; Ham, Seung Mo ; Maeng, Cheol Young ; Lee, Ju Young ; Shin, Yong Je ; Kim, Yong Gil ; Joung, Chan Mi ; Park, Jong Sil ; Ryu, Eun Ju ; Park, Chun Eung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016224227BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Jang, Young Koo</creatorcontrib><creatorcontrib>Kim, Ji Yeon</creatorcontrib><creatorcontrib>Cha, Soo Bong</creatorcontrib><creatorcontrib>Cho, Nahm Ryune</creatorcontrib><creatorcontrib>Min, Hye Kyung</creatorcontrib><creatorcontrib>Jung, Hyo Jun</creatorcontrib><creatorcontrib>Choi, Eun Ju</creatorcontrib><creatorcontrib>Lee, Ji Won</creatorcontrib><creatorcontrib>Han, Seung Nam</creatorcontrib><creatorcontrib>Chung, Jin Yong</creatorcontrib><creatorcontrib>Ham, Seung Mo</creatorcontrib><creatorcontrib>Maeng, Cheol Young</creatorcontrib><creatorcontrib>Lee, Ju Young</creatorcontrib><creatorcontrib>Shin, Yong Je</creatorcontrib><creatorcontrib>Kim, Yong Gil</creatorcontrib><creatorcontrib>Joung, Chan Mi</creatorcontrib><creatorcontrib>Park, Jong Sil</creatorcontrib><creatorcontrib>Ryu, Eun Ju</creatorcontrib><creatorcontrib>Park, Chun Eung</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Jang, Young Koo</au><au>Kim, Ji Yeon</au><au>Cha, Soo Bong</au><au>Cho, Nahm Ryune</au><au>Min, Hye Kyung</au><au>Jung, Hyo Jun</au><au>Choi, Eun Ju</au><au>Lee, Ji Won</au><au>Han, Seung Nam</au><au>Chung, Jin Yong</au><au>Ham, Seung Mo</au><au>Maeng, Cheol Young</au><au>Lee, Ju Young</au><au>Shin, Yong Je</au><au>Kim, Yong Gil</au><au>Joung, Chan Mi</au><au>Park, Jong Sil</au><au>Ryu, Eun Ju</au><au>Park, Chun Eung</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same</title><date>2020-01-16</date><risdate>2020</risdate><abstract>The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2016224227BB2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T03%3A09%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Jang,%20Young%20Koo&rft.date=2020-01-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016224227BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true